Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer Article
Belani, Chandra P., Nemunaitis, John J., Chachoua, Abraham et al. (2013). Phase 2 trial of erlotinib with or without PF-3512676 (CPG 7909, a Toll-like receptor 9 agonist) in patients with advanced recurrent EGFR-positive non-small cell lung cancer
. CANCER BIOLOGY & THERAPY, 14(7), 557-563. 10.4161/cbt.24598
Industry Collaboration